HK1169984A1 - Diphenyl-pyrazolopyridine compounds, their preparation and their application as modulators of the nuclear receptor not - Google Patents
Diphenyl-pyrazolopyridine compounds, their preparation and their application as modulators of the nuclear receptor notInfo
- Publication number
- HK1169984A1 HK1169984A1 HK12110468.8A HK12110468A HK1169984A1 HK 1169984 A1 HK1169984 A1 HK 1169984A1 HK 12110468 A HK12110468 A HK 12110468A HK 1169984 A1 HK1169984 A1 HK 1169984A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- alkyl
- hydroxy
- hydrogen
- group
- alkyl group
- Prior art date
Links
- 108020005497 Nuclear hormone receptor Proteins 0.000 title abstract 2
- 108020004017 nuclear receptors Proteins 0.000 title abstract 2
- 102000006255 nuclear receptors Human genes 0.000 title abstract 2
- PIWSKNFAGSZLBM-UHFFFAOYSA-N 3,5-diphenyl-1h-pyrazolo[4,3-b]pyridine Chemical class C1=CC=CC=C1C1=NNC2=CC=C(C=3C=CC=CC=3)N=C12 PIWSKNFAGSZLBM-UHFFFAOYSA-N 0.000 title 1
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 12
- 125000005843 halogen group Chemical group 0.000 abstract 5
- 229910052739 hydrogen Inorganic materials 0.000 abstract 3
- 239000001257 hydrogen Substances 0.000 abstract 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 3
- 125000004043 oxo group Chemical group O=* 0.000 abstract 3
- 125000004191 (C1-C6) alkoxy group Chemical group 0.000 abstract 2
- 101001109698 Homo sapiens Nuclear receptor subfamily 4 group A member 2 Proteins 0.000 abstract 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 2
- 102100022676 Nuclear receptor subfamily 4 group A member 2 Human genes 0.000 abstract 2
- -1 cyano, hydroxy Chemical group 0.000 abstract 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
- 101000785650 Homo sapiens Zinc finger protein 268 Proteins 0.000 abstract 1
- 101001109694 Rattus norvegicus Nuclear receptor subfamily 4 group A member 2 Proteins 0.000 abstract 1
- 102100026516 Zinc finger protein 268 Human genes 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- 125000004356 hydroxy functional group Chemical group O* 0.000 abstract 1
- 229910052757 nitrogen Inorganic materials 0.000 abstract 1
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Psychology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Addiction (AREA)
- Hospice & Palliative Care (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0958651A FR2953520B1 (fr) | 2009-12-04 | 2009-12-04 | Derives de diphenyl-pyrazolopyridines, leur preparation et leur application en therapeutique |
| PCT/FR2010/052605 WO2011067544A1 (fr) | 2009-12-04 | 2010-12-03 | Derives de diphenyl - pyrazolopyrdines, leur preparation et leur application en tant que modulateurs du recepteur nucleaire not |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1169984A1 true HK1169984A1 (en) | 2013-02-15 |
Family
ID=42111360
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK12110468.8A HK1169984A1 (en) | 2009-12-04 | 2012-10-22 | Diphenyl-pyrazolopyridine compounds, their preparation and their application as modulators of the nuclear receptor not |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US8680096B2 (ru) |
| EP (1) | EP2507238B1 (ru) |
| JP (1) | JP5738310B2 (ru) |
| KR (1) | KR101696959B1 (ru) |
| CN (1) | CN102762559B (ru) |
| AR (1) | AR079250A1 (ru) |
| AU (1) | AU2010326429B2 (ru) |
| BR (1) | BR112012013511A2 (ru) |
| CA (1) | CA2782704C (ru) |
| CL (1) | CL2012001461A1 (ru) |
| CO (1) | CO6551713A2 (ru) |
| EA (1) | EA020652B1 (ru) |
| FR (1) | FR2953520B1 (ru) |
| HK (1) | HK1169984A1 (ru) |
| IL (1) | IL220060A (ru) |
| JO (1) | JO3098B1 (ru) |
| MA (1) | MA33893B1 (ru) |
| MX (1) | MX2012006421A (ru) |
| MY (1) | MY157676A (ru) |
| NZ (1) | NZ600368A (ru) |
| SG (1) | SG181138A1 (ru) |
| TW (1) | TWI481606B (ru) |
| UY (1) | UY33079A (ru) |
| WO (1) | WO2011067544A1 (ru) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2950344B1 (fr) * | 2009-09-18 | 2011-11-25 | Sanofi Aventis | Derives de 5-phenyl-pyrazolopyridine, leur preparation et leur aplication en therapeutique. |
| FR2950345B1 (fr) * | 2009-09-18 | 2011-09-23 | Sanofi Aventis | Derives acetyleniques de 5-phenyl-pyrazolopyridine, leur preparation et leur application en therapeutique |
| WO2018098491A1 (en) | 2016-11-28 | 2018-05-31 | Praxis Precision Medicines, Inc. | Compounds and their methods of use |
| CN116763791A (zh) | 2016-11-28 | 2023-09-19 | 普拉克西斯精密药物股份有限公司 | 化合物以及它们的使用方法 |
| US20210188839A1 (en) * | 2016-11-28 | 2021-06-24 | Praxis Precision Medicines, Inc. | Compounds and their methods of use |
| IL267139B2 (en) * | 2016-12-08 | 2023-03-01 | Bayer Cropscience Ag | A method for the production of 5-(1-phenyl-h1-pyrazol-4-yl)-nicotinamide derivatives and similar compounds without isolation or purification of the phenylhydrazine intermediate |
| WO2018148745A1 (en) | 2017-02-13 | 2018-08-16 | Praxis Precision Medicines , Inc. | Compounds and their methods of use |
| WO2018187480A1 (en) | 2017-04-04 | 2018-10-11 | Praxis Precision Medicines, Inc. | Compounds and their methods of use |
| US11278535B2 (en) | 2017-08-15 | 2022-03-22 | Praxis Precision Medicines, Inc. | Compounds and their methods of use |
| CN117756800A (zh) | 2018-05-30 | 2024-03-26 | 普拉克西斯精密药物股份有限公司 | 离子通道调节剂 |
| US11773099B2 (en) | 2019-05-28 | 2023-10-03 | Praxis Precision Medicines, Inc. | Compounds and their methods of use |
| US11279700B2 (en) | 2019-05-31 | 2022-03-22 | Praxis Precision Medicines, Inc. | Ion channel modulators |
| US11505554B2 (en) | 2019-05-31 | 2022-11-22 | Praxis Precision Medicines, Inc. | Substituted pyridines as ion channel modulators |
| US11767325B2 (en) | 2019-11-26 | 2023-09-26 | Praxis Precision Medicines, Inc. | Substituted [1,2,4]triazolo[4,3-a]pyrazines as ion channel modulators |
| CN111138325B (zh) * | 2019-12-20 | 2021-11-30 | 台州学院 | 一种(Z)-β-磺酰基烯胺类化合物的制备方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2001139575A (ja) * | 1999-11-15 | 2001-05-22 | Fujisawa Pharmaceut Co Ltd | 新規ピラゾロピリジン誘導体 |
| FR2906250B1 (fr) * | 2006-09-22 | 2008-10-31 | Sanofi Aventis Sa | Derives de 2-aryl-6phenyl-imidazo(1,2-a) pyridines, leur preparation et leur application en therapeutique |
| CN101679409B (zh) * | 2006-12-22 | 2014-11-26 | Astex治疗学有限公司 | 双环杂环衍生化合物、其医药组合物和其用途 |
| FR2928923B1 (fr) * | 2008-03-21 | 2010-04-23 | Sanofi Aventis | Derives polysubstitues de 2-heteroaryl-6-phenyl-imidazo °1,2-a!pyridines, leur preparation et leur application en therapeutiques |
| FR2928921B1 (fr) * | 2008-03-21 | 2010-04-23 | Sanofi Aventis | Derives polysubstitues de 2-aryl-6-phenyl-imidazo°1,2-a!pyridines, leur preparation et leur application en therapeutique |
| FR2928924B1 (fr) * | 2008-03-21 | 2010-04-23 | Sanofi Aventis | Derives polysubstitues de 6-heteroaryle-imidazo°1,2-a! pyridines, leur preparation et leur application en therapeutique |
| US8198449B2 (en) * | 2008-09-11 | 2012-06-12 | Bristol-Myers Squibb Company | Compounds for the treatment of hepatitis C |
| FR2950344B1 (fr) * | 2009-09-18 | 2011-11-25 | Sanofi Aventis | Derives de 5-phenyl-pyrazolopyridine, leur preparation et leur aplication en therapeutique. |
-
2009
- 2009-12-04 FR FR0958651A patent/FR2953520B1/fr not_active Expired - Fee Related
-
2010
- 2010-12-02 JO JOP/2010/0430A patent/JO3098B1/ar active
- 2010-12-03 JP JP2012541567A patent/JP5738310B2/ja not_active Expired - Fee Related
- 2010-12-03 EP EP10801625.4A patent/EP2507238B1/fr not_active Not-in-force
- 2010-12-03 MA MA35024A patent/MA33893B1/fr unknown
- 2010-12-03 UY UY33079A patent/UY33079A/es not_active Application Discontinuation
- 2010-12-03 AR ARP100104462A patent/AR079250A1/es unknown
- 2010-12-03 SG SG2012039749A patent/SG181138A1/en unknown
- 2010-12-03 KR KR1020127017287A patent/KR101696959B1/ko active IP Right Grant
- 2010-12-03 EA EA201290520A patent/EA020652B1/ru not_active IP Right Cessation
- 2010-12-03 WO PCT/FR2010/052605 patent/WO2011067544A1/fr active Application Filing
- 2010-12-03 MX MX2012006421A patent/MX2012006421A/es active IP Right Grant
- 2010-12-03 BR BR112012013511A patent/BR112012013511A2/pt not_active IP Right Cessation
- 2010-12-03 TW TW099142230A patent/TWI481606B/zh not_active IP Right Cessation
- 2010-12-03 CA CA2782704A patent/CA2782704C/fr not_active Expired - Fee Related
- 2010-12-03 CN CN201080062600.0A patent/CN102762559B/zh not_active Expired - Fee Related
- 2010-12-03 AU AU2010326429A patent/AU2010326429B2/en not_active Ceased
- 2010-12-03 US US13/513,497 patent/US8680096B2/en not_active Expired - Fee Related
- 2010-12-03 NZ NZ600368A patent/NZ600368A/en not_active IP Right Cessation
- 2010-12-03 MY MYPI2012002449A patent/MY157676A/en unknown
-
2012
- 2012-05-30 IL IL220060A patent/IL220060A/en not_active IP Right Cessation
- 2012-06-04 CL CL2012001461A patent/CL2012001461A1/es unknown
- 2012-06-04 CO CO12093017A patent/CO6551713A2/es active IP Right Grant
- 2012-10-22 HK HK12110468.8A patent/HK1169984A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| JP2013512884A (ja) | 2013-04-18 |
| MY157676A (en) | 2016-07-15 |
| UY33079A (es) | 2011-06-01 |
| CO6551713A2 (es) | 2012-10-31 |
| IL220060A (en) | 2015-05-31 |
| CN102762559A (zh) | 2012-10-31 |
| EP2507238A1 (fr) | 2012-10-10 |
| JP5738310B2 (ja) | 2015-06-24 |
| BR112012013511A2 (pt) | 2016-06-07 |
| AU2010326429B2 (en) | 2016-07-14 |
| US8680096B2 (en) | 2014-03-25 |
| AR079250A1 (es) | 2012-01-04 |
| KR20120103672A (ko) | 2012-09-19 |
| JO3098B1 (ar) | 2017-03-15 |
| CN102762559B (zh) | 2014-11-05 |
| FR2953520B1 (fr) | 2011-11-25 |
| EA201290520A1 (ru) | 2013-01-30 |
| FR2953520A1 (fr) | 2011-06-10 |
| WO2011067544A1 (fr) | 2011-06-09 |
| CA2782704C (fr) | 2018-01-02 |
| US20120245164A1 (en) | 2012-09-27 |
| KR101696959B1 (ko) | 2017-01-16 |
| TW201129564A (en) | 2011-09-01 |
| CL2012001461A1 (es) | 2012-10-12 |
| MA33893B1 (fr) | 2013-01-02 |
| TWI481606B (zh) | 2015-04-21 |
| EA020652B1 (ru) | 2014-12-30 |
| NZ600368A (en) | 2013-12-20 |
| EP2507238B1 (fr) | 2013-07-31 |
| CA2782704A1 (fr) | 2011-06-09 |
| MX2012006421A (es) | 2012-10-09 |
| AU2010326429A1 (en) | 2012-06-21 |
| SG181138A1 (en) | 2012-07-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1169984A1 (en) | Diphenyl-pyrazolopyridine compounds, their preparation and their application as modulators of the nuclear receptor not | |
| HK1136828A1 (en) | Spirocyclic cyclohexane derivatives | |
| SG195319A1 (en) | Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors | |
| TW200800981A (en) | 8-azabicyclo[3.2.1]octane compounds as MU opioid receptor antagonists | |
| TN2011000346A1 (en) | Benzoic acid (1-phenyl-2-pyridin-4-yl)ethyl esters as phosphodiesterase inhibitors | |
| ATE484504T1 (de) | Imidazo ä1,2-aüpyridin-2-carboxamid-derivate, herstellungsverfahren und ihre verwendung für therapeutika | |
| MX2010008101A (es) | Derivados de indol 2-carboxamidas y de azaindol 2-carboxamidas sustituidos con un silanilo, su preparacion y su aplicacion en terapeutica. | |
| MY170822A (en) | Ethynyl derivatives as mglur5 allosteric modulators | |
| MX2010002171A (es) | Compuestos 8-azabiciclo[3.2.1] octil-2 hidroxibenzamida como antagonistas de los receptores opioides mu. | |
| ATE446089T1 (de) | 2-benzoyl-imidazopyridin-derivate, herstellungsverfahren und ihre verwendung für therapeutika | |
| WO2009118473A3 (fr) | Composés dérivés d'azétidines, leur préparation et leur application en thérapeutique | |
| MY183111A (en) | 3-(heteroaryl-amino)-1,2,3,4-tetrahydro-9h-carbazole derivatives and their use as prostaglandin d2 receptor modulators | |
| MX2016003422A (es) | Imidazo[1,2-a]piridina-7-aminas como herramientas de imagen. | |
| MY165634A (en) | Pyrazole compounds having therapeutic effect on multiple myeloma | |
| CO6341560A2 (es) | Proceso para la preparacion de derivados de pirimidina sustituidos. | |
| MY183288A (en) | Novel octahydrothienoquinoline derivative, pharmaceutical composition comprising derivative, and use of these | |
| MX2011012068A (es) | Nucleosidos 2'-fluoro arabino y su utilizaicon. | |
| MX2013013262A (es) | Derivados de ciclododecadienona como ingredientes de perfumado. | |
| MX2009006266A (es) | Procedimientos de preparacion de 3-(4-(2,4-difluorobenciloxi)-3-br omo-6-metil-2-oxopiridin-1 (2h)-il)-n,4-dimetilbenzamida. | |
| GB0617867D0 (en) | Chemical compounds | |
| MX2010007348A (es) | Derivados de n-fenil-imidazo[1,2-a]piridin-2-carboxamidas, su preparacion y su aplicacion terapeutica. | |
| SG153774A1 (en) | New 1h-indol-1-yl-urea compounds, a process for their preparation and pharmaceutical compositions containing them | |
| TH135903B (th) | อนุพันธ์ของไดเฟนิล-พิแรโซโลพิริดีน, การเตรียมสารเหล่านั้น, และการใช้สารนั้นเป็นตัวควบคุม nuclear receptor not | |
| ZA200905205B (en) | 2-piperazin-1-yl-3H-imidazo[4,5-B]pyridine derivatives | |
| TH135903A (th) | อนุพันธ์ไดเฟนิล-พิแรโซโลพิริดีน, การเตรียมสารเหล่านั้น, และการใช้สารนั้นเป็นตัวควบคุม nuclear receptor not |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20181201 |